EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access

Stakeholder Perspectives on the Integration of AI in Diabetes Care: Systematic Review of Qualitative Studies

Perspektiven von Stakeholdern zur Integration von KI in die Diabetesversorgung: systematische Übersichtsarbeit qualitativer Studien

Héctor Martínez-Martínez, Julia Martínez-Alfonso, Belén Sánchez-Rojo-Huertas, María Eugenia Visier-Alfonso, Fernando Sebastián-Valles, Ana Díez-Fernández, Ana Pérez-Moreno, Vicente Martínez-Vizcaíno

Journal of Medical Internet Research · 22.09.2026 · 28 · e105329-e105329

DOI: 10.2196/105329 ↗

Auf einen Blick

14 qualitative Studien zeigen: Stakeholder sahen KI in der Diabetesversorgung als potenziell hilfreich für Prävention, individuelle Betreuung, Schulung, Selbstmanagement und Entscheidungen. Genannt wurden auch wichtige Bedenken.

Fragestellung

Welche Perspektiven haben Patient:innen, Angehörige, Gesundheitsfachpersonen und weitere Stakeholder zur Integration von KI in das Diabetesmanagement?

Methode

Systematische Übersichtsarbeit qualitativer Studien; Suche in MEDLINE, Web of Science, Scopus, CINAHL und PsycINFO bis 17. Februar 2026; thematische Synthese; Bewertung mit JBI, CAMELOT und GRADE-CERQual.

Ergebnisse

14 Studien von 2023 bis 2025 mit mindestens 738 Teilnehmenden aus 9 Ländern. 4 Themen und 13 Subthemen; 11 Befunde hohe, 2 moderate Zuversicht. KI wurde als nützlich wahrgenommen, aber auch mit Bedenken verbunden.

Einschränkungen

Heterogene KI-Modalitäten, Stakeholdergruppen, Diabeteskontexte und Technologieexposition; demografische Ungleichgewichte; eingeschränkte Reflexivitätsberichte; häufig Prototypen oder hypothetische Systeme.

Schlussfolgerung der Autor:innen

Obwohl Stakeholder KI als nützlich für die Diabetesversorgung wahrnahmen, zeigen diese qualitativen Befunde keine klinische Wirksamkeit, Sicherheit oder bessere Patientenergebnisse.

Kernaussagen

  • KI wurde mit Unterstützung für Prävention, Bildung, Selbstmanagement und Entscheidungen verbunden.
  • Bedenken betrafen Genauigkeit, Bias, Datenschutz, Haftung und zusätzliche Arbeitsbelastung.
  • Gefordert wurden Transparenz, klinische Validierung, Datenschutz, menschliche Aufsicht und Unterstützung.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Medical Internet Research, online erschienen am 22.09.2026. Verfasst von Héctor Martínez-Martínez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Health and Social Research Center, Universidad de Castilla-La Mancha, Cuenca, Castilla-La Mancha, Spain. Hauptthemen laut MEDLINE: Diabetes Mellitus, Artificial Intelligence, Stakeholder Participation. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

AI is increasingly being integrated into diabetes care, with growing evidence supporting its potential to improve clinical decision-making, risk prediction, and self-management. However, the lived experiences, expectations, and concerns of those involved in its implementation have not been adequately synthesized.

Objective

This study aims to synthesize qualitative evidence on the perspectives of patients, caregivers, health care professionals (HCPs), and other stakeholders regarding the integration of AI in diabetes management.

Methods

We searched MEDLINE via PubMed, Web of Science, Scopus, CINAHL, and PsycINFO from inception to February 17, 2026. Eligible studies examined the perspectives of adult patients, caregivers, health care professionals, or administrators on AI-enabled tools for diabetes management, self-management, clinical decision support, or the prevention of complications, and used qualitative methods or reported a separately analyzable qualitative component. Tools required an identifiable data-driven function for prediction, classification, recommendation, personalization, or decision support. Studies focused exclusively on image-based diagnosis, technical validation, or digital tools without an identifiable AI component were excluded. Two reviewers (HM-M and JM-A) independently screened studies and extracted data. Methodological limitations were assessed using the Joanna Briggs Institute (JBI) checklist and the Cochrane Qualitative Methodological Limitations Tool (CAMELOT). Findings were synthesized using thematic synthesis. Confidence was assessed using GRADE-CERQual. A sensitivity analysis excluded questionnaire-based qualitative evidence.

Results

Fourteen studies published between 2023 and 2025 were included, representing at least 738 participants across 9 countries. Participants included individuals with type 1 or type 2 diabetes, family caregivers, doctors, nurses, specialists, administrators, and other health care staff. Studies evaluated large language models, AI-enabled mobile applications and wearables, glucose-prediction systems, and clinical decision-support tools. Exposure ranged from direct use of functioning systems to evaluation of prototypes, wireframes, and hypothetical applications. Four analytical themes and 13 subthemes were identified. Stakeholders perceived that AI could support preventive and individualized care, education, self-management, and decision-making. Concerns included accuracy, bias, privacy, accountability, increased workload, caregiver burden, loss of professional autonomy, and erosion of human-centered care. Participants emphasized explainability, intuitive design, integration with existing systems, tailored training, and continued access to human support. Eleven findings were rated as high confidence and 2 as moderate confidence.

Conclusions

Although stakeholders perceived AI to be useful for diabetes care, these qualitative findings do not demonstrate clinical effectiveness, safety, or improved patient outcomes. Evidence was limited by heterogeneity in AI modalities, stakeholder groups, diabetes contexts, and technology exposure, as well as demographic imbalance, restricted reporting of researcher reflexivity, and reliance on prototype or hypothetical systems. Implementation should prioritize transparent design, clinical validation, data governance, human oversight, and tailored support, while preserving professional judgment and person-centered relationships.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes MellitusArtificial IntelligenceStakeholder ParticipationHumansQualitative ResearchDigital HealthHealth Personnel

Stichwörter der Autor:innen

artificial intelligencediabetes mellitusdigital healthqualitative researchstakeholder perspectivestrust

Autor:innen und Institutionen

  • Health and Social Research Center, Universidad de Castilla-La Mancha, Cuenca, Castilla-La Mancha, Spain.
  • Primary Care Center Zona 7-Feria, Servicio de Salud de Castilla La Mancha, Albacete, Castilla-La Mancha, Spain.
  • Hospital Universitario de Cuenca, Institute of Health Research of Castilla-La Mancha (IDISCAM), Cuenca, Castilla-La Mancha, Spain.
  • Daroca Primary Care Center, Madrid Health Service, Av. de Daroca, 4, Cdad. Lineal, Madrid, 28017, Spain, 34 600 20 92 09.
  • Instituto de investigación del Hospital Universitario de La Princesa. Universidad Autónoma de Madrid, Hospital Universitario de La Princesa, Madrid, Spain.
  • Faculty of Health Sciences, Universidad Autónoma de Chile, Talca, Araucanía, Chile.

Zitieren

APA

Martínez-Martínez, H., Martínez-Alfonso, J., Sánchez-Rojo-Huertas, B., Visier-Alfonso, M. E., Sebastián-Valles, F., Díez-Fernández, A., Pérez-Moreno, A., & Martínez-Vizcaíno, V. (2026). Stakeholder Perspectives on the Integration of AI in Diabetes Care: Systematic Review of Qualitative Studies. Journal of Medical Internet Research, 28, e105329-e105329. https://doi.org/10.2196/105329

Vancouver

Martínez-Martínez H, Martínez-Alfonso J, Sánchez-Rojo-Huertas B, Visier-Alfonso ME, Sebastián-Valles F, Díez-Fernández A, et al. Stakeholder Perspectives on the Integration of AI in Diabetes Care: Systematic Review of Qualitative Studies. Journal of Medical Internet Research. 2026;28:e105329-e105329. doi:10.2196/105329

BibTeX
@article{MartnezMartnez2026,
  author = {Martínez-Martínez, Héctor and Martínez-Alfonso, Julia and Sánchez-Rojo-Huertas, Belén and Visier-Alfonso, María Eugenia and Sebastián-Valles, Fernando and Díez-Fernández, Ana and Pérez-Moreno, Ana and Martínez-Vizcaíno, Vicente},
  title = {Stakeholder Perspectives on the Integration of AI in Diabetes Care: Systematic Review of Qualitative Studies},
  journal = {Journal of Medical Internet Research},
  year = {2026},
  volume = {28},
  pages = {e105329--e105329},
  doi = {10.2196/105329}
}
Kostenlos starten →